Feature

What should employers know to successfully run a group income protection scheme without running into legal problems? Paul Avis and Vanessa Cowling give their insights.

It is worth the time and effort to explain the value of a product to the buyer, writes Alan Lakey.

Recently in the news after alarming statistics detailing its prevalence, Non-melanoma skin cancer is a public health menace. PruProtect's Fergus Bescoby explains the implications

There is a chance that not only will stem cell therapy enter the mainstream, but that IFAs will be advising on it. As a pilot opens in the UK, Sue Wilkinson outlines the case.

The downgrading of protection's value post purchase is a prime factor in making it a grudge purchase, according to recent research. Jo Miller says better contact with customers is key to changing consumer attitudes.

Robin Hyndley looks at what the latest DWP proposals mean for employers and employees, and explores how insurers could provide appropriates in the current environment.

For such a well-known condition, MS is difficult to pin down, as Neil Hartigan explains.

Protection providers will soon be considering customer telematics. Phil Jeynes examines the consequences.

A change in pension tax rules could land some with group life policies with hefty bills. But, as Nick Rumble finds, there are solutions.

Pension reforms are driving the most prominent changes in group life. Fiona Murphy takes a look at market developments.